Summary of the Accelerated regulatory system in Japan
Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) recently issued new regulatory pathways of Conditional Early Approval and SAKIGAKE designation in addition to Priority review and Orphan Disease Drug.
